The clinical impact of echocardiography on antibiotic prophylaxis use in patients with suspected mitral valve prolapse

American Journal of Medicine

Volumn 102, Issue 4, 1997, Pages 337-343

  Heidenreich, Paul A ^a   Bear, Jeffrey ^b   Brower, Warren ^c   Foster, Elyse ^b  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL ENDOCARDITIS; DRUG INDICATION; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MITRAL VALVE PROLAPSE; PRIORITY JOURNAL;

ADULT; ANTIBIOTIC PROPHYLAXIS; ECHOCARDIOGRAPHY; ENDOCARDITIS, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE PROLAPSE;

EID: 0030926761     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)00084-3     Document Type: Article

References (26)

1. Savage DD, Garrison RJ, Devereux RB, et al. Mitral valve prolapse in the general population. 1. Epidemiologic features: the Framingham Study. Am Heart J. 106:1983;571-576.
2. Wann LS, Grove JR, Hess TR, et al. Prevalence of mitral prolapse by two dimensional echocardiography in healthy young women. Br Heart J. 49:1983;334-340.
3. Bryhn M, Persson S. The prevalence of mitral valve prolapse in healthy men and women in Sweden. An echocardiographic study. Acta Med Scand. 215:1984;157-160.
4. Clemens JD, Horwitz RI, Jaffe CC, et al. A controlled evaluation of the risk of bacterial endocarditis in persons with mitral-valve prolapse. NEJM. 307:1982;776-781.
5. MacMahon SW, Roberts JK, Kramer FR, et al. Mitral valve prolapse and infective endocarditis. Am Heart J. 113:1987;1291-1298.
6. Devereux RB, Kramer FR, Kligfield P. Mitral valve prolapse: causes, clinical manifestations, and management. Ann Intern Med. 111:1989;305-317.
7. Dajani AS, Bisno AL, Chung KJ, et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA. 264:1990;2919-2922.
8. Barron JT, Manrose DL, Liebson PR. Comparison of auscultation with two-dimensional and Doppler echocardiography in patients with suspected mitral valve prolapse. Clin Cardiol. 11:1988;401-406.
9. Gal RA, Volkert P, Malik I, et al. Fee-for-service versus capitation-based reimbursement: How the payment method affects utilization of echocardiographic services by referring physicians. Echocardiogr. 12:1995;207-211.
10. Marks AR, Choong CY, Sanfilippo AJ, et al. Identification of high-risk and low-risk subgroups of patients with mitral-valve prolapse. NEJM. 320:1989;1031-1036.
11. McKinsey DS, Ratts TE, Bisno AL. Underlying cardiac lesions in adults with infective endocarditis. The changing spectrum. Am J Med. 81:1987;681-688.
12. Nishimura RA, McGoon MD, Shub C, et al. Echocardiographically documented mitral-valve prolapse. Long-term follow-up of 237 patients. NEJM. 313:1985;1305-1309.
13. Popp RL, Fortuin NJ, Johnson ML, Kisslo Jr. Optimal resources for ultrasonic examination of the heart. Echocardiography study group. Circulation. 65:1982;423A-431A.
14. Hershman WY, Moskowitz MA, Marton FI, Balady GJ. Utility of echocardiography in patients with suspected mitral valve prolapse. Am J Med. 87:1989;371-376.
15. Olive KE, Grassman ED. Impact of echocardiography on the management of patients with mitral valve prolapse. J Gen Intern Med. 5:1990;470-473.
16. Retchin SM, Waugh RA, Fletcher RH. The impact of echocardiographic results on treatment decisions for patients suspected of mitral valve prolapse. Med Care. 25:1987;652-657.
17. Blumlein S, Bouchard A, Schiller NB, et al. Quantitation of mitral regurgitation by Doppler echocardiography. Circulation. 74:1986;306-314.
18. Miyatake K, Izumi S, Okamoto M, et al. Semiquantitative grading of severity of mitral regurgitation by real-time two-dimensional Doppler flow imaging technique. J Am Coll Cardiol. 7:1986;82-88.
19. Transition I. A Functional Overview. 1989;Transition Systems, Inc, Boston, Massachusetts.
20. Mangione S, Nieman LZ, Gracely E, Kaye D. The teaching and practice of cardiac auscultation during internal medicine and cardiology training. A nationwide survey. Ann Intern Med. 119:1993;47-54.
21. Goldman L, Cohn PF, Mudge GJ, et al. Clinical utility and management impact of M-mode echocardiography. Am J Med. 75:1983;49-56.
22. Olive KE, Grassman ED. Mitral valve prolapse: comparison of diagnosis by physical examination and echocardiography. South Med J. 83:1990;1266-1269.
23. Clemens JD, Ransohoff DF. A quantitative assessment of pre-dental antibiotic prophylaxis for patients with mitral-valve prolapse. J Chronic Dis. 37:1984;531-544.
24. Bor DH, Himmelstein DU. Endocarditis prophylaxis for patients with mitral valve prolapse. A quantitative analysis. Am J Med. 76:1984;711-717.
25. Gould IM, Buckingham JK. Cost effectiveness of prophylaxis in dental practice to prevent infective endocarditis. Br Heart J. 70:1993;79-83.
26. Fleg JL, Hinton PC, Lakatta EG, et al. Physician utilization of laboratory procedures to monitor outpatients with congestive heart failure. Arch Intern Med. 149:1989;393-396.